PsychedeLinks is a weekly digest of news, business, and culture in the psychedelics industry curated by members of Emerge Law Group’s groundbreaking Psychedelics Industry Group.
Decriminalization, Legalization, and Other State Efforts
Colorado Polls Show Conflicting Results On Psychedelics Ballot Measure That Voters Will Decide On In November
Psychedelics reform is on the ballot in Colorado this November, and two recent polls paint conflicting pictures about how voters will come down on the historic initiative. For both surveys, respondents were given a description of the measure, which seeks to legalize possession of psychedelics like p…
Psychedelics Decriminalization In Oregon: An Update On Voters’ Stance
Oregon voters said yes to all-psychedelics possession decriminalization in 2020’s state ballot, and a recent poll by Data for Progress showed that the majorly stand by
Oregon Psilocybin Services Act
Therapeutic Psilocybin Mushrooms are Pure Potential, If We Allow Them
Yamhill County commissioner explains the benefits of the controversial therapy
Deschutes County Still Drafting Psilocybin Facility Rules, in Case November Opt-Out Ballot Measure Fails
The Deschutes County Planning Commission will conduct a public hearing Thursday evening to receive testimony on proposed land use regulations related to psilocybin manufacturing and the establishment of psilocybin service centers in the unincorporated county.
Right to Try
DEA Suggests Doctor Seeking Psilocybin For Terminally Ill Patients Has Financial Interest, So It Won’t Waive Records Fee
The Drug Enforcement Administration (DEA) is suggesting that a doctor seeking psilocybin for terminally ill patients under federal “Right to Try” (RTT) laws has a financial interest that renders him ineligible to get a fee waiver for records requested by his attorney. Sunil Aggarwal, a Washington St…
Therapy, Research, & Science
The Psychedelic Remedy for Chronic Pain
Drugs best known for their hallucinogenic properties, such as psilocybin, could help people beat the agony of migraines and other painful maladies.
Amid Veteran Suicide Crisis, First US Pilot Program for MDMA and Psilocybin Treatment Moves Forward
Veterans spoke before Congress about the urgency of making psychedelic treatment accessible and affordable.
Business
Cybin Obtains Exclusive License to a Novel Catalog of Psychedelic-Based Compounds
Cybin Inc. (NEO:CYBN) (NYSE AMERICAN:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics
Global Psychedelics Company Silo Wellness Acquires Dyscovry Science, Including Access To Its Gov Collaborations
According to information procured exclusively by Benzinga ahead of an official announcement, global psychedelics company Silo Wellness Inc.
Subscribe
Subscribe to PsychedeLinks to receive essential weekly articles on news, business, and culture in the psychedelics industry, delivered straight to your inbox.
